BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 90 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $72,000 | -21.7% | 68,434 | +25.9% | 0.00% | -20.0% |
Q2 2019 | $92,000 | +80.4% | 54,339 | +256.6% | 0.01% | +66.7% |
Q1 2019 | $51,000 | +18.6% | 15,239 | +4.3% | 0.00% | 0.0% |
Q4 2018 | $43,000 | -74.9% | 14,615 | -47.5% | 0.00% | -62.5% |
Q3 2018 | $171,000 | -70.4% | 27,828 | -68.4% | 0.01% | -65.2% |
Q1 2018 | $577,000 | -33.6% | 88,012 | +105.3% | 0.02% | -43.9% |
Q4 2015 | $869,000 | +246.2% | 42,878 | +148.2% | 0.04% | +355.6% |
Q3 2015 | $251,000 | – | 17,278 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 918,000 | $11,328,000 | 4.35% |
EMORY UNIVERSITY | 164,607 | $2,031,000 | 1.92% |
Monashee Investment Management LLC | 160,000 | $1,974,000 | 0.79% |
UNIVERSITY OF NOTRE DAME DU LAC | 210,260 | $2,595,000 | 0.65% |
CORRADO ADVISORS, LLC | 83,622 | $1,032,000 | 0.59% |
Foresite Capital Management II, LLC | 105,000 | $1,296,000 | 0.56% |
Baker Brothers Advisors | 5,032,313 | $62,099,000 | 0.51% |
SPHERA FUNDS MANAGEMENT LTD. | 200,000 | $2,468,000 | 0.48% |
Clearline Capital LP | 55,200 | $681,000 | 0.32% |
LMR Partners LLP | 270,594 | $3,339,000 | 0.32% |